Sam Chun Dang Pharm. Co., Ltd
KOE: 000250.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Chun In Seok
- Employees
- 375
- Headquarters
- Seoul, South Korea
- IPO year
- 2001
- Market cap
- ₩9.4T
- Website
- http://www.scd.co.kr
Loading 000250…
Loading profile data…Frequently asked questions about 000250
What does Sam Chun Dang Pharm. Co., Ltd (000250.KQ) do?
SAM CHUN DANG PHARM Co., Ltd. engages in the manufacture of pharmaceuticals. Its products include antibiotics, cures for the circulatory and respiratory system, medicines for the digestive system and ophthalmology, and anti-inflammatory. The company was founded on December 29, 1943 and is headquartered in Hwaseong-si, South Korea.
Where does 000250.KQ trade?
Sam Chun Dang Pharm. Co., Ltd (000250.KQ) trades on the KOSDAQ.
What sector is 000250.KQ in?
Sam Chun Dang Pharm. Co., Ltd (000250.KQ) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Sam Chun Dang Pharm. Co., Ltd?
Chun In Seok is the chief executive officer of Sam Chun Dang Pharm. Co., Ltd (000250.KQ).
Where is Sam Chun Dang Pharm. Co., Ltd headquartered?
Sam Chun Dang Pharm. Co., Ltd is headquartered in South Korea.
Does 000250.KQ pay a dividend?
Yes — Sam Chun Dang Pharm. Co., Ltd (000250.KQ) paid a trailing twelve-month dividend of KRW 50.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 000250.KQ go public?
Sam Chun Dang Pharm. Co., Ltd (000250.KQ) completed its initial public offering in 2001.